Susquehanna International Group
ACUR

Susquehanna International Group’s Acura Pharmaceuticals ACUR Stock Holding History

Susquehanna International Group’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,240
Closed -$12K – 10346
2014
Q2 		$12K Sell
2,240
-1,300
-37% -$7.88K ﹤0.01% 9698
2014
Q1 		$26K Buy
3,540
+620
+21% +$5.38K ﹤0.01% 8768
2013
Q4 		$24K Sell
2,920
-5,180
-64% -$43.8K ﹤0.01% 8890
2013
Q3 		$77K Sell
8,100
-4,460
-36% -$39.4K ﹤0.01% 8158
2013
Q2 		$118K Buy
+12,560
New +$142K ﹤0.01% 7725

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Susquehanna International Group's ACUR Position: Q3 2015 in Review

Susquehanna International Group sold out of Acura Pharmaceuticals (ACUR) in Q3 2015, closing a stake of 2,052 shares — an estimated $10K sold.

Susquehanna International Group first reported a position in ACUR in Q3 2013 and held it in 6 quarters. The position peaked at $60K in Q3 2013. 22 funds tracked by Wall St. Rank hold ACUR as of Q3 2015.

  • Susquehanna International Group reported no remaining Acura Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Susquehanna International Group sold 2,052 Acura Pharmaceuticals shares in Q3 2015, an estimated $10K.
  • Susquehanna International Group first reported a position in Acura Pharmaceuticals in Q3 2013 and held it in 6 quarters.
  • Susquehanna International Group's Acura Pharmaceuticals position peaked at $60K in Q3 2013.
  • 22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2015.

Based on Susquehanna International Group's 13F filing for Q3 2015, filed 16 Nov 2015.